Abstract: A method of fabricating a semiconductor device include; seating a substrate having a substrate radius on an electrostatic chuck, applying first radio-frequency power to the electrostatic chuck to induce plasma in a region at least above the electrostatic chuck, and generating a magnetic field in the region at least above the electrostatic chuck using a magnet having a ring-shape and disposed above the electrostatic chuck by applying second radio-frequency power to the magnet, wherein the magnet has an inner radius ranging from about one-half to about one-fourth of the substrate radius.

Abstract: The present disclosure relates to a device for fastening a lockbolt, the device comprising: a lockbolt gun including a body unit having a grip therein for pulling the lockbolt and a gripping unit protruding from a lower portion of the body unit and having an operation switch installed on the outside, wherein a hydraulic supply flow path for supplying hydraulic pressure for driving the grip, a hydraulic discharge flow path for discharging hydraulic pressure supplied to the grip, and an air supply flow path for supplying pneumatic pressure to the operation switch are installed in the gripping unit, and a discharge hole is formed outside the gripping unit to discharge air from the air supply flow path when the operation switch is operated; a driving force supply unit having a hydraulic supply pump that supplies hydraulic pressure to the hydraulic supply flow path, a hydraulic recovery pump that recovers hydraulic pressure discharged from the hydraulic discharge flow path, and an oil tank that supplies oil to the

Abstract: Provided is a composition for preventing hair loss or promoting hair development, comprising, as an active ingredient, irone or a pharmaceutically acceptable salt thereof. More specifically, provided is a pharmaceutical composition, a quasi-drug composition, a cosmetic composition, or a health functional food composition, for preventing hair loss, treating hair loss, promoting hair development, or promoting hair growth, the composition comprising irone or a salt thereof as an active ingredient. The composition not only contains, as an active ingredient, a natural compound having no adverse effects even when administered for a long period of time with respect to hair loss, a chronic disease, but also exhibits excellent and stable efficacy in hair development and hair growth, which allows the composition to be usefully used as an agent for preventing or treating hair loss, or a pharmaceutical, quasi-drug, cosmetic, or health functional food composition for promoting hair development or hair growth.

Abstract: A light emitting diode comprises first and second electrodes facing each other; a first charge generation layer between the first and second electrodes; a first emitting stack including a first emitting material layer between the first electrode and the first charge generation layer and a first electron transporting layer between the first emitting material layer and the first charge generation layer; and a second emitting stack including a second emitting material layer between the first charge generation layer and the second electrode and a second electron transporting layer between the second emitting material layer and the second electrode, wherein the first charge generation layer has an electron mobility lower than that of the first electron transporting layer.

Abstract: The present invention relates to a composition for allergy prevention, atopic dermatitis alleviation or skin regeneration, containing, as an active ingredient, undecane or undecanal and, more specifically, to a composition for preventing or treating allergic disease or atopic dermatitis and a composition for healing skin wound or promoting skin regeneration, both of which contain, as an active ingredient, at least one selected from a group consisting of undecane, undecanal or pharmaceutically acceptable salts thereof.

Abstract: Proposed are a naphthalene-based hydrogen storage material including a naphthalene group, the naphthalene-based hydrogen storage material being capable of being used as a hydrogen storage media for supplying hydrogen to a device using hydrogen such as a fuel cell and a hydrogen combustion device, and to a method of storing and releasing hydrogen using the same. The hydrogen storage material can exhibit a significantly high hydrogen capacity, and can have excellent cost competitiveness with the use of a low-cost organic compound which is commercially available in the art.

Abstract: Proposed is a carbon dioxide reforming (CDR) reactor having a multilayered catalyst layer arrangement for preventing catalyst deactivation, wherein, in the reactor in which a CDR reaction for reacting methane (CH4) with carbon dioxide (CO2) to reform the methane into a synthesis gas including carbon monoxide (CO) and hydrogen (H2) is performed, in order to prevent a case where an endothermic reaction between a catalyst and heated reactant gas supplied to the reactor gradually causes the temperature of the reactant gas to decrease and the catalyst is deactivated by cokes generated due to the decrease in temperature of the reactant gas, CDR catalysts in the reactor are arranged in multiple layers in a multilayered structure to allow the reactant gas temperature that has decreased due to the endothermic reaction to be restored in spaces between the catalyst layers.

Abstract: The present invention relates to a method of directly preparing a dicarbamate compound from a diamine compound, and more particularly to a method of directly preparing a dicarbamate compound by reacting a diamine compound with an alcohol compound in the presence of a mixed gas of carbon monoxide (CO) and oxygen (O2) using a Pd/MOx catalyst configured such that a palladium (Pd) active metal is supported on a metal oxide or metalloid oxide carrier.

Abstract: An electronic device is provided. The electronic device includes a touchscreen display; first communication circuitry to establish a short-range communication connection; second communication circuitry to establish a cellular communication connection; and a processor.

Abstract: The present invention relates to a pharmaceutical composition containing a sesquiterpene derivative or a pharmaceutically acceptable salt thereof as an active ingredient for the prevention or treatment of muscle diseases.

Abstract: An electric vehicle charging control system may include an electric vehicle which extracts current time information, the integrity of which has been verified, by use of a public key cryptography, and charges power from a charging terminal, when it is determined that a charging contact certificate is valid, based on the extracted current time information, a server to transmit the current time information, the integrity of which has been verified using the public key cryptography, to the electric vehicle, and the charging terminal connected to the electric vehicle. The validity of the certificate used in vehicle charging and billing for charging is determined through the power line communication, and the security against the hacking is enhanced in the charging of the electric vehicle.

Abstract: An electronic device is provided. The electronic device includes a first communication module configured to establish a communication channel to an external electronic device based on wired communications or short-range communications, a second communication module that supports a communication service provided via a base station; a control module configured to obtain a communication profile required for operating the second communication module using the external electronic device connected through the first communication module, and a memory configured to store the communication profile.

Abstract: The present invention relates to a composition for preventing or treating a muscular disease or improving muscle function. The composition includes suberic acid or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: The present invention relates to a pharmaceutical composition comprising pinocarveol for preventing or treating metabolic diseases, and functional food composition using the pharmaceutical composition for improving or alleviating metabolic diseases. Pinocarveol according to the present invention reduces weight, visceral fat, and cholesterol concentration, improves blood liver function index, reduces blood sugar, and additionally inhibits a metabolic inflammation reaction, and thus can be effectively used ultimately as a medical or functional food composition exhibiting prevention or treatment activities for metabolic diseases selected from the group consisting of obesity, diabetes, dyslipidemia, and syndromes of fatty liver and insulin-resistance.

Abstract: An electronic device is provided. The electronic device includes a housing, a display configured to be exposed through one surface of the housing, a communication module configured to communicate over a first network compliant with a first protocol or a second network compliant with a second protocol, a processor configured to be electrically connected with the display and the communication module, and a memory configured to be electrically connected with the processor and store a specified application. The memory stores instructions, that when executed, cause the processor 420 to execute the specified application, designate a CP server by interacting with a platform server over the second network, receive an initial response message generated by the designated CP server over the first network, and verify a first identifier of the designated CP server based on the first protocol from a source of the initial response message.

Abstract: A manufacturing method thereof, and the catalyst for removing the nitrogen oxide includes a powdery gamma alumina support on which at least one selected from a group of titanium (Ti), lanthanum (La), or zirconium (Zr) is supported, wherein the support may be further supported with iridium (Ir) and ruthenium (Ru).

Abstract: Disclosed are: a communication technique and a system therefor for fusing, with IoT technology, a 5G communication system for supporting a data transmission rate higher than that of a 4G system. Provided is a method for installing a profile of a terminal having an embed universal integrated circuit card (eUICC) in a mobile communication system, the method comprising: requesting for an eUICC authentication certificate to an eUICC and receiving the eUICC authentication certificate; and transferring a profile package to the eUICC so as to install a profile, wherein the received eUICC authentication certificate further comprises an eUICC manufacturer (EUM) authentication certificate.

Abstract: The present invention relates to a monolith catalyst for carbon-dioxide/methane reforming and a method of manufacturing the same, and more particularly to a novel monolith catalyst for a reforming reaction having improved thermal durability, configured such that a sintering inhibiting layer is formed by coating the surface of a monolith support with at least one element selected from the group consisting of Group 2, 3, 6, 13, 15 and 16 elements among elements in Period 3 or higher and an active catalyst layer is formed on the sintering inhibiting layer, thereby preventing carbon deposition and catalyst deactivation due to deterioration even upon reaction at high temperatures.

Abstract: The present disclosure relates to a communication technique for combining a 5G communication system for supporting a higher data transmission rate than a 4G system with an IoT technology, and a system therefor. The present disclosure can be applied to 5G communication and IoT related technology-based intelligent services (for example, smart homes, smart buildings, smart cities, smart cars or connected cars, health care, digital education, retail business, security and safety related services, etc.).

Abstract: A disease network construction method includes the steps of: (1) organizing cohort data in time series; (2) stratifying or grouping the data organized in step (1) by confounding variables; (3) deriving a correlation of diseases within the stratification in step (2); and (4) constructing a disease network on the basis of the correlation derived in step (3). According to the present invention, a disease may be influenced by a variety of clinical and medical confounding variables such as age, gender, race, socioeconomic variables, and regional and national health care systems, and thus a method for more reliably deriving a correlation between diseases may be provided.